BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 18695388)

  • 1. Evaluation of recent fixed-dose combination therapies in the management of hypertension.
    Khanna A; Lefkowitz L; White WB
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):477-83. PubMed ID: 18695388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing hypertension using combination therapy.
    Frank J
    Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
    Neutel JM
    Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes.
    Roca-Cusachs A; Schmieder RE; Triposkiadis F; Wenzel RR; Laurent S; Kohlmann O; Fogari R;
    J Hypertens; 2008 Apr; 26(4):813-8. PubMed ID: 18327093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
    Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME; Epstein BJ
    J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
    Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining RAAS and calcium channel blockade: ACCOMPLISH in perspective.
    Kjeldsen SE; Weber M; Oparil S; Jamerson KA
    Blood Press; 2008; 17(5-6):260-9. PubMed ID: 19061055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When antihypertensive monotherapy fails: fixed-dose combination therapy.
    Weir MR
    South Med J; 2000 Jun; 93(6):548-56. PubMed ID: 10881767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The combination of an ACE inhibitor and a calcium channel blocker is an optimal combination for the treatment of hypertension].
    Widimský J
    Vnitr Lek; 2009 Feb; 55(2):123-30. PubMed ID: 19348394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypertension combination therapy with renin-angiotensin system blockers].
    Soucek M
    Vnitr Lek; 2009 Sep; 55(9):719-23. PubMed ID: 19785368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with ACE inhibitors/angiotensin II receptor antagonists and diuretics in hypertension.
    Waeber B
    Expert Rev Cardiovasc Ther; 2003 May; 1(1):43-50. PubMed ID: 15030296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving blood pressure control and clinical outcomes through initial use of combination therapy in stage 2 hypertension.
    White WB
    Blood Press Monit; 2008 Apr; 13(2):123-9. PubMed ID: 18347448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
    Abe M; Okada K; Matsumoto K
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.
    Patel BV; Remigio-Baker RA; Thiebaud P; Preblick R; Plauschinat C
    BMC Fam Pract; 2008 Nov; 9():61. PubMed ID: 18990240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial therapy for uncomplicated hypertension: insights from the alphabetic maze of recent studies.
    Stewart JR; Yeun JY
    Minerva Med; 2003 Aug; 94(4):215-27. PubMed ID: 14605587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of hypertension management: the role of angiotensin receptor blocker-calcium channel blocker combinations.
    Parati G
    J Cardiovasc Pharmacol; 2009 May; 53(5):352-8. PubMed ID: 19365281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fixed combinations of antihypertensive medications--new opportunity in treatment of hypertension].
    Laganović M
    Lijec Vjesn; 2010; 132(3-4):94-8. PubMed ID: 20540436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension.
    Bramlage P
    Expert Opin Pharmacother; 2009 Aug; 10(11):1755-67. PubMed ID: 19538001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.